BioCardia (BCDA) Institutional Ownership $1.45 0.00 (0.00%) Closing price 03:59 PM EasternExtended Trading$1.40 -0.05 (-3.38%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BioCardia (NASDAQ:BCDA)CurrentInstitutional OwnershipPercentage20.57%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$346.73KNumber ofInstitutional Sellers(last 12 months)0 Get BCDA Insider Trade Alerts Want to know when executives and insiders are buying or selling BioCardia stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data BCDA Institutional Buying and Selling by Quarter BioCardia Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2025Cetera Investment Advisers20,275$40K0.0%N/A0.369% 5/9/2025CM Management LLC75,000$190K0.2%+200.0%1.472% 4/30/2025Brown Advisory Inc.35,538$90K0.0%N/A0.759% 2/12/2025Geode Capital Management LLC30,987$68K0.0%+110.3%0.677% 2/7/2025CM Management LLC25,000$54K0.0%N/A0.546% 11/7/2023CM Management LLC600,000$258K0.3%+74.9%2.775% 8/4/2023CM Management LLC343,000$916K0.9%+4.3%1.677% 7/24/2023Vontobel Holding Ltd.30,751$82K0.0%+93.5%0.150% 5/15/2023AIGH Capital Management LLC509,151$994K0.4%-14.5%2.523% 4/12/2023Vontobel Holding Ltd.15,895$31K0.0%N/A0.079% 2/16/2023AIGH Capital Management LLC595,237$1.24M0.4%N/A2.969% 11/15/2022Family Management Corp142,186$276K0.1%N/A0.797% 5/4/2022Commonwealth Equity Services LLC49,978$103K0.0%+18.1%0.296% 1/31/2022Commonwealth Equity Services LLC42,307$82K0.0%+156.5%0.251% 11/5/2021Advisor Group Holdings Inc.39,257$124K0.0%-8.4%0.233% 10/29/2021Commonwealth Equity Services LLC16,492$51K0.0%N/A0.098% 9/17/2021Virtu Financial LLC33,264$132K0.0%N/A0.197% 8/25/2021Marshall Wace LLP21,680$86K0.0%-45.7%0.129% 8/16/2021Marshall Wace LLP21,680$86K0.0%-45.7%0.129% 8/13/2021Renaissance Technologies LLC102,230$406K0.0%-66.5%0.609% 8/13/2021Geode Capital Management LLC76,825$304K0.0%+23.6%0.457% 8/13/2021Vanguard Group Inc.411,969$1.64M0.0%+67.8%2.453% (Data available from 1/1/2016 forward) BCDA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCDA shares? During the previous two years, the following institutional investors and hedge funds held shares of BioCardia shares: CM Management LLC ($190K), Brown Advisory Inc. ($90K), and Geode Capital Management LLC ($68K), Cetera Investment Advisers ($40K).Learn more on BioCardia's institutional investors. What percentage of BioCardia's stock is owned by institutional investors? 20.57% of BioCardia's stock is owned by institutional investors. Learn more on BCDA's institutional investor holdings. Which institutional investors have been buying BioCardia's stock? The following institutional investors have purchased BioCardia's stock in the last 24 months: CM Management LLC ($332K), Brown Advisory Inc. ($35.54K), Cetera Investment Advisers ($20.28K), and Geode Capital Management LLC ($16.25K). How much institutional buying is happening at BioCardia? Institutional investors have bought a total of 147,064 shares in the last 24 months. This purchase volume represents approximately $346.73K in transactions. Related Companies AKTX Major Shareholders DARE Major Shareholders CVKD Major Shareholders KZR Major Shareholders ENLV Major Shareholders RNTX Major Shareholders PMN Major Shareholders XCUR Major Shareholders MIRA Major Shareholders NNVC Major Shareholders This page (NASDAQ:BCDA) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
